Mar 11, 2024, 17:58
Melvin Chua: Interesting results from LEAP010 – combo Pembro with Levatinib or Carbozatinib
Melvin Chua, Head of the Department of Head Neck and Thoracic Cancers, Division of Radiation Oncology at National Cancer Centre Singapore, shared on X/Twitter:
“Interesting results from LEAP010 – combo Pembro with Levatinib or Carbozatinib. Evidently increased ORR, possibly PFS but no difference in OS
Loss of OS signal due to effective salvage regimens?”
Source: Melvin Chua/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 15, 2024, 21:29
Oct 15, 2024, 18:57
Oct 15, 2024, 18:54
Oct 15, 2024, 17:41
Oct 15, 2024, 17:37
Oct 15, 2024, 17:36
Oct 15, 2024, 17:32
Oct 15, 2024, 17:26
Oct 15, 2024, 17:20